Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations - PubMed

• PMID: 25946288
• DOI: 10.1056/NEJMms1502493

Free article

Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations

Lisa Rosenbaum. N Engl J Med. 2015.

Free article

Comment in

• Conflicts of Interest.

  Rosenbaum L. Rosenbaum L. N Engl J Med. 2015 Aug 20;373(8):779-80. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287861 No abstract available.

• Conflicts of Interest.

  Abramson J, Redberg R. Abramson J, et al. N Engl J Med. 2015 Aug 20;373(8):778. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287862 No abstract available.

• Conflicts of Interest.

  Roper N. Roper N. N Engl J Med. 2015 Aug 20;373(8):778. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287863 No abstract available.

• Conflicts of Interest.

  Fleischman W, Newman DH. Fleischman W, et al. N Engl J Med. 2015 Aug 20;373(8):778-9. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287864 No abstract available.

• Conflicts of Interest.

  Strandberg TE. Strandberg TE. N Engl J Med. 2015 Aug 20;373(8):779. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287865 No abstract available.

Similar articles

• Conflicts of Interest.

  Strandberg TE. Strandberg TE. N Engl J Med. 2015 Aug 20;373(8):779. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287865 No abstract available.

• Conflicts of Interest.

  Fleischman W, Newman DH. Fleischman W, et al. N Engl J Med. 2015 Aug 20;373(8):778-9. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287864 No abstract available.

• Conflicts of Interest.

  Roper N. Roper N. N Engl J Med. 2015 Aug 20;373(8):778. doi: 10.1056/NEJMc1507811. N Engl J Med. 2015. PMID: 26287863 No abstract available.

• Conflict of interest in the physician interface with the biomedical industry.

  Minnigan H, Chisholm CD. Minnigan H, et al. Emerg Med Clin North Am. 2006 Aug;24(3):671-85. doi: 10.1016/j.emc.2006.05.008. Emerg Med Clin North Am. 2006. PMID: 16877136 Review.

• Review article: gastroenterology and the pharmaceutical industry.

  Rakatansky H. Rakatansky H. Aliment Pharmacol Ther. 2002 Nov;16(11):1859-66. doi: 10.1046/j.1365-2036.2002.01362.x. Aliment Pharmacol Ther. 2002. PMID: 12390094 Review.

Cited by

• Effect of different financial competing interest statements on readers' perceptions of clinical educational articles: a randomised controlled trial.

  Schroter S, Pakpoor J, Morris J, Chew M, Godlee F. Schroter S, et al. BMJ Open. 2019 Feb 19;9(2):e025029. doi: 10.1136/bmjopen-2018-025029. BMJ Open. 2019. PMID: 30782923 Free PMC article. Clinical Trial.

• The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.

  Bandari J, Turner RM 2nd, Jacobs BL, Canes D, Moinzadeh A, Davies BJ. Bandari J, et al. Urol Pract. 2017 Jan;4(1):14-20. doi: 10.1016/j.urpr.2016.03.007. Urol Pract. 2017. PMID: 28149927 Free PMC article.

• Facts and ideas from anywhere.

  Roberts WC. Roberts WC. Proc (Bayl Univ Med Cent). 2015 Oct;28(4):541-52. doi: 10.1080/08998280.2015.11929336. Proc (Bayl Univ Med Cent). 2015. PMID: 26424966 Free PMC article. No abstract available.

• Health Professionals "Make Their Choice": Pharmaceutical Industry Leaders' Understandings of Conflict of Interest.

  Grundy Q, Tierney L, Mayes C, Lipworth W. Grundy Q, et al. J Bioeth Inq. 2017 Dec;14(4):541-553. doi: 10.1007/s11673-017-9804-y. Epub 2017 Sep 14. J Bioeth Inq. 2017. PMID: 28913595

• Characteristics and conflicts of interest at Food and Drug Administration Gastrointestinal Drug Advisory Committee meetings.

  Khan R, Elsolh K, Gimpaya N, Scaffidi MA, Bansal R, Grover SC. Khan R, et al. PLoS One. 2021 May 26;16(5):e0252155. doi: 10.1371/journal.pone.0252155. eCollection 2021. PLoS One. 2021. PMID: 34038480 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.